pretickt

Is CTVA a good stock to buy?

Corteva, Inc. · end-of-day data as of Nov 13, 2026

Corteva
CTVA · $6.29B
$9.43+2.6%
Nov 13, 2026 · close
$10$12$14Nov9:3016:003 months -25.0%Nov 13 · close
▲ 5
  • PT$16.22 +72.0%
  • ConsensusBuy · 15
  • P/E vs sector-62.6%
  • RSI30
  • Bollingerbelow lower
Neutral
  • Earnings in81d
  • P/E7.8x
  • Volume1.3x
  • P/E vs own-0.6%
  • ATR+7.6%
  • InsidersNone in 90d
▼ 3
  • FCF yield-2.4%
  • News
  • Sector▼ -7.0%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Corteva a good stock to buy?

Corteva is weak on demand; advantage, economics, execution and fragility in between. The price is low: 7.8 times its earnings, below its 3-year median of 18.1 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand shrinking
  2. Advantage some edge
  3. Economics profitable
  4. Execution mixed
  5. Fragility some risks
  6. Price below its usual
DemandDo people want more of what it sells?shrinking

CTVA sales growth revenue growth

0%a year, for the last 3 years

Corteva's sales fell 0% a year for 3 years, to $17.4B in fiscal 2025.

CTVA peers

pretickt analysis+1%its sales in 12 months, on a year before

Corteva's sales grew 1% in the 12 months to Sep 30, 2026, faster than Mosaic (-3%), slower than Hecla (+30%), Albemarle (+24%) and CF Industries (+18%).

Advantage moatIs it hard to copy?some edge

CTVA return on capital ROIC

pretickt analysis26%earned before tax on the money invested in it

Corteva earned 26% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Hecla 35%, CF Industries 24%, Albemarle 8% and Mosaic -2%.

CTVA margin on each sale gross margin

49%left after making the product

Corteva kept 49% of each sale after making the product in the 12 months to Sep 30, 2026; its peers' median is 34%.

EconomicsDoes it make good money?profitable

CTVA margin after costs profit margin

16%of sales left after running the business

Corteva's operating margin was 16% in the 12 months to Sep 30, 2026, against 11% in fiscal 2022.

CTVA cash generated free cash flow

-$149Mcash left after investing, last 12 months

Corteva burned $149M of cash in the 12 months to Sep 30, 2026, after its investments.

ExecutionDoes it deliver what it promises?mixed

CTVA earnings vs estimates

5 of 7quarters above the analysts' estimate

Corteva beat the analysts' profit estimate in 5 of 7 quarters, the latest on Nov 11, 2026; 1 quarter with one-time gains or charges is left out.

CTVA insider selling

-$636Ksold, net, by its executives in 12 months

Corteva's executives and directors sold a net $636K of shares in the 12 months to Nov 13, 2026; none bought.

CTVA number of employees

-2%fewer people in a year

Corteva had 21,500 employees at the end of fiscal 2025, 2% fewer than a year before.

CTVA CEO pay

$17.5Mfor fiscal 2025, 67% of it in stock and options

Corteva paid its CEO $17.5M for fiscal 2025, 67% of it in stock and options.

Fragility risksCould something break it?some risks

CTVA financial health Altman Z-score

0.9Altman Z-score, safe above 3

Corteva's Altman Z-score is 0.9 (Nov 13, 2026), below 1.8, the distress zone.

CTVA quality checks Piotroski score

7 of 9checks passed

Corteva passes 7 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on cash against profit and long-term debt.

CTVA shareholders institutional ownership

pretickt analysis
  • Vanguard11.0% ▼
  • BlackRock8.0% ▼
  • Capital Group6.4% ▲
1,525institutions hold it; the largest sold shares

1,525 institutions hold 89% of Corteva's shares (Jun 30, 2026); Capital Group added shares that quarter, Vanguard and BlackRock sold some.

Price valuationIs the price reasonable?below its usual

CTVA price vs profit P/E ratio

7.8×a year's earnings

Corteva's P/E ratio is 7.8 (Nov 13, 2026), below its 3-year median of 18.1.

CTVA price vs peers

pretickt analysis7.8×a year's earnings, against its peers

Investors pay 7.8 times Corteva's earnings (Nov 13, 2026), less than for Albemarle (24.4), Hecla (23.4) or CF Industries (8.8).

CTVA analysts' target price target

+72%to their average target

Analysts' average price target for Corteva is $16.22, 72% above the Nov 13, 2026 close of $9.43.

CTVA analyst ratings, 90 days

pretickt analysis
  • JP Morganupgrade
  • Keybancupgrade
2 up, 0 downratings raised and cut

In the 90 days to Nov 13, 2026, JP Morgan and Keybanc upgraded Corteva.

What is Corteva's P/E ratio?

Corteva's P/E ratio is 7.8 (Nov 13, 2026), below its 3-year median of 18.1. Investors pay 7.8 times Corteva's earnings (Nov 13, 2026), less than for Albemarle (24.4), Hecla (23.4) or CF Industries (8.8).

Is Corteva profitable?

Corteva's operating margin was 16% in the 12 months to Sep 30, 2026, against 11% in fiscal 2022. Corteva burned $149M of cash in the 12 months to Sep 30, 2026, after its investments.

Are insiders selling Corteva stock?

Corteva's executives and directors sold a net $636K of shares in the 12 months to Nov 13, 2026; none bought.

Who owns Corteva stock?

1,525 institutions hold 89% of Corteva's shares (Jun 30, 2026); Capital Group added shares that quarter, Vanguard and BlackRock sold some.

How many employees does Corteva have?

Corteva had 21,500 employees at the end of fiscal 2025, 2% fewer than a year before.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.